Fas Ligand (CD95L) and Cancer Gene Therapy

被引：0
|
作者：
Gary J. Nabel
机构：
[1] National Institutes of Health,
[2] Vaccine Research Center,undefined
来源：
Nature Biotechnology | 1999年 / 17卷 / Suppl 4期
关键词：
D O I：
10.1038/70149
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 25
相关论文
共 50 条
  • [1] Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer
    Shimizu, M
    Yoshimoto, T
    Matsuzawa, A
    Takeda, Y
    MOLECULAR BIOTECHNOLOGY, 2003, 25 (01) : 79 - 87
  • [2] Modification of tumor cells with fas (CD95) antigen gene and fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer
    Motomu Shimizu
    Takayuki Yoshimoto
    Akio Matsuzawa
    Yasutaka Takeda
    Molecular Biotechnology, 2003, 25 : 79 - 87
  • [3] Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy
    Aoki, K
    Akyürek, LM
    San, H
    Leung, K
    Parmacek, MS
    Nabel, EG
    Nabel, GJ
    MOLECULAR THERAPY, 2000, 1 (06) : 555 - 565
  • [4] Regulation of the proinflammatory effects of Fas ligand (CD95L)
    Chen, JJ
    Sun, YN
    Nabel, GJ
    SCIENCE, 1998, 282 (5394) : 1714 - 1717
  • [5] Tumor expression of Fas ligand (CD95L) and the consequences
    Walker, PR
    Saas, P
    Dietrich, PY
    CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 564 - 572
  • [6] Cellular localization and function of Fas ligand (CD95L) in tumors
    Kurooka, M
    Nuovo, GJ
    Caligiuri, MA
    Nabel, GJ
    CANCER RESEARCH, 2002, 62 (05) : 1261 - 1265
  • [7] Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes
    Büssing, A
    Stein, GM
    Pfüller, U
    Schietzel, M
    ANTICANCER RESEARCH, 1999, 19 (3A) : 1785 - 1790
  • [8] Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism
    Nabipour, Iraj
    Kalantarhormozi, Mohammadreza
    Assadi, Majid
    Jafari, Seyed Mojtaba
    Gharibi, Mohammad
    Ahmadi, Esmaeil
    Sanjdideh, Zahra
    ENDOCRINE, 2010, 38 (03): : 406 - 411
  • [9] Fas (CD95), Fas ligand (CD95L), and Bcl-2 expression in human placenta and umbilical cord.
    Uckan, D
    Steele, A
    Wang, B
    Chamizo, W
    Koutsonikolis, A
    Good, RA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 114 - 114
  • [10] Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism
    Iraj Nabipour
    Mohammadreza Kalantarhormozi
    Majid Assadi
    Seyed Mojtaba Jafari
    Mohammad Gharibi
    Esmaeil Ahmadi
    Zahra Sanjdideh
    Endocrine, 2010, 38 : 406 - 411
12345